The CTLA-4 +49GG genotype is associated with susceptibility for nephrotic kidney diseases

Nephrology Dialysis Transplantation

Volumn 28, Issue 11, 2013, Pages 2800-2805

  Spink, Clemens ^a   Stege, Gesa ^a   Tenbrock, Klaus ^b   Harendza, Sigrid ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

CTLA 4; Focal segmental glomerulosclerosis; Membranous nephropathy; Minimal change disease; Singlenucleotide polymorphism

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 GENE; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; GENE; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENOTYPE; GENOTYPING TECHNIQUE; HETEROZYGOTE DETECTION; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; MOLECULAR DYNAMICS; NEPHROTIC SYNDROME; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

CTLA-4; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; MEMBRANOUS NEPHROPATHY; MINIMAL-CHANGE DISEASE; SINGLE-NUCLEOTIDE POLYMORPHISM;

ADULT; CASE-CONTROL STUDIES; CTLA-4 ANTIGEN; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLOMERULONEPHRITIS, MEMBRANOUS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; MALE; MIDDLE AGED; NEPHROSIS, LIPOID; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS;

EID: 84890073601     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft381     Document Type: Article

References (27)

1. Couser WG. Basic and translational concepts of immunemediated glomerular diseases. J Am Soc Nephrol 2012; 23: 381-399
2. McCarthy ET, Sharma M, Savin VJ. Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 2010; 5: 2115-2121
3. Wei C, Trachtman H, Li J et al. Circulating suPAR in two cohorts of primary FSGS. J Am Soc Nephrol 2012; 23: 2051-2059
4. Garin EH, Mu W, Arthur JM et al. Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis. Kidney Int 2010; 78: 296-302
5. Karandikar NJ, Vanderlugt CL, Walunas TL et al. CTLA-4: a negative regulator of autoimmune disease. J Exp Med 1996; 184: 783-788
6. McCoy KD, Le Gros G. The role of CTLA-4 in the regulation of T cell immune responses. Immunol Cell Biol 1999; 77: 1-10
7. Shimada M, Araya C, Rivard C et al. Minimal change disease: a 'two hit' podocytes immune disorder? Pediatr Nephrol 2011; 26: 645-649
8. Clement LC, Liu G, Perez-Torres I et al. Early changes in gene expression that influence the course of primary glomerular disease. Kidney Int 2007; 72: 337-347
9. Nishikawa K, Linsley PS, Collins AB et al. Effect of CTLA-4 chimeric protein on rat autoimmune anti-glomerular basement membrane glomerulonephritis. Eur J Immunol 1994; 24: 1249-1254
10. Azuma H, Chandraker A, Nadeau K et al. Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection. Proc Natl Acad Sci USA 1996; 93: 12439-12444
11. Ueda H, Howson JM, Esposito L et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003; 423: 506-511
12. Ligers A, Teleshova N, Masterman T et al. CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun 2001; 2: 145-152
13. Carr EJ, Niederer HA, Williams J et al. Confirmation of the genetic association of CTLA4 and PTPN22 with ANCA-associated vasculitis. BMC Med Genet 2009; 10: 121
14. Mäurer M, Loserth S, Kolb-Mäurer A et al. A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1 +49) alters T-cell activation. Immunogenetics 2002; 54: 1-8
15. Wang JJ, Shi YP, Yue H et al. CTLA-4 exon 1 +49A/G polymorphism is associated with renal involvement in pediatric Henoch-Schönlein purpura. Pediatr Nephrol 2012; 27: 2059-2064
16. Du L, Yang J, Huang J et al. The associations between the polymorphism in the CTLA-4 gene and the risk of Graves' disease in the Chinese population. BMC Med Genet 2013; 14: 46
17. Lei C, Dongqing Z, Yeqing S et al. Association of the CTLA-4 gene with rheumatoid arthritis in Chines Han population. Eur J Hum Genet 2005; 13: 823-828
18. Bao L, Haas M, Pippin J et al. Focal and segmental glomerulosclerosis induced in mice lacking decay-accelerating factor in T cells. J Clin Invest 2009; 119: 1264-1274
19. Heymann F, Meyer-Schwesinger C, Hamilton-Williams EE et al. Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury. J Clin Invest 2009; 119: 1286-1297
20. Munkert A, Helmchen U, Kemper MJ et al. Characterization of the transcriptional regulation of the human MT1-MMP gene and association of risk reduction for focal-segmental glomerulosclerosis with two functional promoter SNPs. Nephrol Dial Transplant 2009; 24: 735-742
21. Kouki T, Gardine CA, Anagawa T et al. Relation of three polymorphisms of the CTLA-4 gene in patients with Graves' disease. J Endocrinol Invest 2002; 25: 208-213
22. Li M, Zheng H, Li T et al. Cytotoxic T-lymphocyte associated antigen-4 gene polymorphisms and primary biliary cirrhosis: a systematic review. J Gastroenterol Hepatol 2012; 27: 1159-1166
23. Valk E, Rudd CE, Schneider H. CTLA-4 trafficking and surface expression. Trends Immunol 2008; 29: 272-279
24. Anjos S, Nguyen A, Ounissi-Benkalha H et al. A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in insufficient glycosylation of the susceptibility allele. J Biol Chem 2002; 277: 46478-46486
25. Beck LH, Jr, Bonegio RG, Lambeau G et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009; 36: 11-21
26. Liu Y, Liang WB, Gao LB et al. CTLA4 and CD86 gene polymorphisms and susceptibility to chronic obstructive pulmonary disease. Hum Immunol 2010; 71: 1141-1146
27. Waterhouse P, Penninger JM, Timms E et al. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 1995; 270: 985-988